Among 9 analysts covering Integra Lifesciences Holdings Corp. (NASDAQ:IART), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Integra Lifesciences Holdings Corp. had 14 analyst reports since July 29, 2015 according to SRatingsIntel. As per Thursday, June 2, the company rating was maintained by Barclays Capital. The rating was upgraded by JMP Securities on Friday, January 6 to “Mkt Outperform”. The company was downgraded on Monday, August 24 by Zacks. The company was maintained on Wednesday, August 26 by Lake Street. The stock of Integra Lifesciences Holdings Corp (NASDAQ:IART) earned “Buy” rating by Lake Street on Friday, October 28. The stock has “Buy” rating by Citigroup on Thursday, November 12. The rating was initiated by UBS with “Buy” on Monday, December 12. Bank of America upgraded the shares of IART in report on Monday, September 21 to “Buy” rating. The stock has “Overweight” rating by JP Morgan on Monday, August 3. The company was initiated on Wednesday, July 13 by JP Morgan. See Integra Lifesciences Holdings Corp (NASDAQ:IART) latest ratings:
13/01/2017 Broker: RBC Capital Markets Rating: Sector Perform Old Target: $85 New Target: $46 Maintain
06/01/2017 Broker: JMP Securities Old Rating: Mkt Perform New Rating: Mkt Outperform Upgrade
12/12/2016 Broker: UBS Rating: Buy New Target: $96 Initiate
28/10/2016 Broker: Lake Street Old Rating: Hold New Rating: Buy New Target: $92.00 Upgrade
Among 2 analysts covering Navient Corporation (NDAQ:NAVI), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Navient Corporation has $20 highest and $17 lowest target. $18.50’s average target is 22.44% above currents $15.11 stock price. Navient Corporation had 2 analyst reports since April 7, 2017 according to SRatingsIntel. The rating was maintained by Wood with “Buy” on Friday, April 7. The firm has “Hold” rating by BMO Capital Markets given on Wednesday, April 12.
Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.21, from 1.34 in 2016Q3. It worsened, as 37 investors sold Integra Lifesciences Holdings Corp shares while 58 reduced holdings. 29 funds opened positions while 78 raised stakes. 33.92 million shares or 4.02% more from 32.61 million shares in 2016Q3 were reported. Breton Hill Capital Limited invested in 0.07% or 6,202 shares. Mutual Of America Lc has invested 0.04% in Integra Lifesciences Holdings Corp (NASDAQ:IART). Grp Inc Inc, a New York-based fund reported 22,103 shares. Federated Investors Inc Pa stated it has 0% of its portfolio in Integra Lifesciences Holdings Corp (NASDAQ:IART). Ls Limited Liability stated it has 0.01% in Integra Lifesciences Holdings Corp (NASDAQ:IART). Independent Port Consultants Inc accumulated 0.34% or 12,075 shares. Wells Fargo Mn owns 0.06% invested in Integra Lifesciences Holdings Corp (NASDAQ:IART) for 2.09 million shares. Geode Mngmt Ltd Liability reported 0.01% of its portfolio in Integra Lifesciences Holdings Corp (NASDAQ:IART). Allianz Asset Mgmt Ag has 0.01% invested in Integra Lifesciences Holdings Corp (NASDAQ:IART) for 155,940 shares. Blackrock Grp, a United Kingdom-based fund reported 61,430 shares. Delaware-based Blackrock Advisors Lc has invested 0% in Integra Lifesciences Holdings Corp (NASDAQ:IART). Huntington Bankshares accumulated 932 shares. Art Advisors Ltd Liability stated it has 0.04% in Integra Lifesciences Holdings Corp (NASDAQ:IART). 4,004 are owned by Amalgamated Bank & Trust. Texas Permanent School Fund holds 21,814 shares or 0.02% of its portfolio.
Integra LifeSciences Holdings Corporation is a medical technology company. The company has market cap of $3.11 billion. The Firm focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. It has a 44.54 P/E ratio. The Company’s divisions include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions.
The stock increased 1.24% or $0.51 during the last trading session, reaching $41.6. About 630,764 shares traded or 17.78% up from the average. Integra Lifesciences Holdings Corp (NASDAQ:IART) has declined 3.71% since September 12, 2016 and is downtrending. It has underperformed by 12.20% the S&P500.
Investors sentiment increased to 0.93 in Q4 2016. Its up 0.11, from 0.82 in 2016Q3. It improved, as 33 investors sold Navient Corp shares while 144 reduced holdings. 52 funds opened positions while 112 raised stakes. 269.82 million shares or 2.85% less from 277.73 million shares in 2016Q3 were reported. Barclays Public Limited Liability Company reported 265,053 shares or 0% of all its holdings. Credit Agricole S A holds 0.27% of its portfolio in Navient Corp (NASDAQ:NAVI) for 5.14 million shares. Deutsche Bank & Trust Ag invested in 0.02% or 1.36M shares. Janus Capital Limited Liability invested in 0.04% or 2.96 million shares. Moreover, Leuthold Grp Lc has 0.45% invested in Navient Corp (NASDAQ:NAVI) for 244,271 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 61,915 shares stake. Barrow Hanley Mewhinney Strauss Limited Liability Com reported 0.8% in Navient Corp (NASDAQ:NAVI). Balasa Dinverno Foltz Lc holds 0.05% or 16,383 shares. Ngam Advisors Lp has 40,126 shares for 0.01% of their portfolio. Moreover, Sterling Cap Mgmt Ltd Liability has 0.03% invested in Navient Corp (NASDAQ:NAVI). Louisiana State Employees Retirement Sys holds 0.02% in Navient Corp (NASDAQ:NAVI) or 19,100 shares. Outfitter Advsr owns 58,300 shares or 0.38% of their US portfolio. Joel Isaacson And Ltd Llc has 0.01% invested in Navient Corp (NASDAQ:NAVI). Brinker Cap stated it has 0.02% in Navient Corp (NASDAQ:NAVI). Jefferies Gru Ltd stated it has 37,549 shares.
The stock increased 0.40% or $0.06 during the last trading session, reaching $15.11. About 4.94M shares traded or 105.83% up from the average. Navient Corp (NDAQ:NAVI) has risen 4.51% since September 12, 2016 and is uptrending. It has underperformed by 3.97% the S&P500.
